Pharma-Bio Serv (PBSV) Other Non-Current Assets (2010 - 2026)

Pharma-Bio Serv's Other Non-Current Assets history runs 16 years deep, the most recent figure standing at $120771.0 for Q2 2026.

• Other Non-Current Assets for Q2 2026 came in at $120771.0, down 46.48% year-over-year; the trailing twelve-month figure through Apr 2026 was $120771.0 (down 46.48% YoY), and the FY2025 annual result was $120754.0, down 46.47% from the prior year.
• Other Non-Current Assets came in at $120771.0 for Q2 2026 at Pharma-Bio Serv, roughly flat from $120783.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $353294.0 in Q1 2022 to a low of $111665.0 in Q4 2023.
• A 5-year average of $171390.8 and a median of $130523.0 in 2022 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets sank 63.14% in 2023 and surged 102.06% in 2025, its largest moves.
• Over 5 years, Other Non-Current Assets stood at $130874.0 in 2022, then dropped by 14.68% to $111665.0 in 2023, then soared by 102.03% to $225599.0 in 2024, then sank by 46.47% to $120754.0 in 2025, then advanced by 0.01% to $120771.0 in 2026.
• The last three Other Non-Current Assets figures came in at $120771.0 (Q2 2026), $120783.0 (Q1 2026), and $120754.0 (Q4 2025), per Business Quant data.